Exogenous antigen-driven Th cell–CLL cell interaction has been shown to drive CLL B-cell activation and differentiation into IgM-secreting PCs that did not downregulate HLA and costimulatory molecules or express the PC marker CD138. The gene discussed is SDC1; the disease is B-cell chronic lymphocytic leukemia.